The board of directors of Johnson & Johnson (NYSE:JNJ) authorised a common stock cash dividend of USD1.01 per share for the first quarter of 2021, the company reported on Monday.
With an ex-dividend date of 22 February 2021, the dividend will be paid on 9 March 2021 to shareholders of record at the close of business on 23 February 2021.
Johnson & Johnson researches and develops, manufactures and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical and Medical Devices.
The company was founded in 1886 and is based in New Brunswick, New Jersey, USA.
CVS Health declares unchanged quarterly dividend
ALK partners with GenSci to expand allergy immunotherapy market in China
Curatis secures Swiss distribution deal with Phoenix Labs
Innocan Pharma reports 'positive swing' in operating profitability for first half of 2025
Wolters Kluwer boosts medical research efficiency with Ovid AI summarisation
European Commission approves Gilead's twice-yearly HIV prevention injection Yeytuo
Essa Pharma clarifies Nasdaq due bill trading period for cash distribution
Advanz Pharma and Alvotech secure European approval for aflibercept biosimilar Mynzepli
Heron Therapeutics announces tax benefits preservation plan adoption
Essa Pharma sets ex-dividend date and due bill trading for USD80m capital return
BioDlink's bevacizumab injection secures Colombia and Pakistan marketing authorisation
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement
Everest Medicines expands I-MAB investment
Perrigo Announces Quarterly Dividend
Ridgetech reports net income of USD10.20m in fiscal year 2025